The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Yusef Yu.

Krasnov Research Institute of Eye Disease

Telyatov B.A.

Krasnov Research Institute of Eye Disease

Petrachkov D.V.

Krasnov Research Institute of Eye Disease

Veliyeva I.A.

Krasnov Research Institute of Eye Disease

Fedoruk N.A.

Krasnov Research Institute of Eye Disease

Current view on the diagnosis of metamorphopsia in macular pathology

Authors:

Yusef Yu., Telyatov B.A., Petrachkov D.V., Veliyeva I.A., Fedoruk N.A.

More about the authors

Journal: Russian Annals of Ophthalmology. 2025;141(5): 94‑100

DOI: 10.17116/oftalma202514105194

Read: 760 times

Contact the author
Table of contents

CURRENT VIEW ON THE DIAGNOSIS OF METAMORPHOPSIA IN MACULAR PATHOLOGY
CURRENT VIEW ON THE DIAGNOSIS OF METAMORPHOPSIA IN MACULAR PATHOLOGY

To cite this article:

Yusef Yu, Telyatov BA, Petrachkov DV, Veliyeva IA, Fedoruk NA. Current view on the diagnosis of metamorphopsia in macular pathology. Russian Annals of Ophthalmology. 2025;141(5):94‑100. (In Russ.)
https://doi.org/10.17116/oftalma202514105194

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Abstract:

This review addresses the current state of quantitative assessment of metamorphopsia. The article briefly describes the main symptoms of macular pathology as well as diseases associated with the development of metamorphopsia, defines the concept of metamorphopsia, and outlines different approaches to its classification. A substantial part of the review focuses on diagnostic methods for metamorphopsia, particularly the most widely used techniques for its quantitative evaluation. In addition, the work analyzes the main advantages and limitations inherent to these methods. It is substantiated that no optimal method for the quantitative assessment of metamorphopsia currently exists.

Keywords:

macular pathology
metamorphopsias
methods of quantitative assessment of metamorphopsias

Authors:

Yusef Yu.

Krasnov Research Institute of Eye Disease

Telyatov B.A.

Krasnov Research Institute of Eye Disease

Petrachkov D.V.

Krasnov Research Institute of Eye Disease

Veliyeva I.A.

Krasnov Research Institute of Eye Disease

Fedoruk N.A.

Krasnov Research Institute of Eye Disease

Received:

06.02.2025

Accepted:

09.04.2025

Close metadata

References:

  1. Al-Asadi SZ. Vitreous floaters and photopsia as predictors of vitreoretinal pathology. Basrah Journal of Surgery. 2013;19(1):50-55.  https://doi.org/10.33762/BSURG.2013.73618
  2. Kulikov AN, Leongardt TA, Maltsev DS. Optical coherence tomography angiography in paracentral acute middle maculopathy (a case report). Russian Annals of Ophthalmology. 2018;134(5):72-77. (In Russ.). https://doi.org/10.17116/oftalma201813405172
  3. Arnold JJ. Age-related macular degeneration: anti-vascular endothelial growth factor treatment. BMJ Clinical Evidence. 2016;2016:0701 
  4. Querques G, Berboucha E, Leveziel N, Pece A, Souied EH. Preferential hyperacuity perimeter in assessing responsiveness to ranibizumab therapy for exudative age-related macular degeneration. British Journal of Ophthalmology. 2011;95(7):986-991.  https://doi.org/10.1136/BJO.2010.190942
  5. Wang H, Khuu SK, Lam S, Lin C, Kalloniatis M, Phu J. Validation of a novel functional test for assessing metamorphopsia using epiretinal membranes as a model. Scientific Reports. 2020;10(1):14938. https://doi.org/10.1038/S41598-020-71627-1
  6. Grigoryeva VN, Mashkovich KA. Metamorphopsia in neurologic practice. Neurology, neuropsychiatry, psychosomatics. 2019;11(4):111-116. (In Russ.). https://doi.org/10.14412/2074-2711-2019-4-111-116
  7. Watanabe A, Arimoto S, Nishi O. Correlation between Metamorphopsia and Epiretinal Membrane Optical Coherence Tomography Findings. Ophthalmology. 2009;116(9):1788-1793. https://doi.org/10.1016/J.OPHTHA.2009.04.046
  8. Midena E, Vujosevic S. Metamorphopsia: An Overlooked Visual Symptom. Ophthalmic Research. 2015;55(1):26-36.  https://doi.org/10.1159/000441033
  9. Jackson TL, Nicod E, Simpson A, Angelis A, Grimaccia F, Kanavos P. Symptomatic vitreomacular adhesion. Retina. 2013;33(8):1503-1511. https://doi.org/10.1097/IAE.0b013e31829232fd
  10. Osaka R, Muraoka Y, Nagasato D, Mitamura Y, Nishigori N, Murakami T, Suzuma K, Tabuchi H, Tsujikawa A. Binocular metamorphopsia in patients with branch retinal vein occlusion: a multi-center study. International Ophthalmology. 2023;43(9):3279-3286. https://doi.org/10.1007/s10792-023-02731-0
  11. Bushuev AV, Andreev AN, Svetozarskiy SN. Spontaneous separation of secondary epiretinal membrane. Russian Annals of Ophthalmology. 2018;134(2): 73-77. (In Russ.). https://doi.org/10.17116/oftalma2018134273-77
  12. Nallamasa RG, Chhablani J. Epiretinal Membrane Management. In: Chang A, Mieler WF, Ohji M, eds. Macular Surgery: Current Practice and Trends. Springer Singapore; 2020:203-212.  https://doi.org/10.1007/978-981-15-7644-7_15
  13. Matoba R, Morizane Y. Surgical Treatment of Epiretinal Membrane. Acta Medica Okayama. 2021;75(4):403-413.  https://doi.org/10.18926/AMO/62378
  14. Chua PY, Sandinha MT, Steel DH. Idiopathic epiretinal membrane: progression and timing of surgery. Eye. 2022;36(3):495-503.  https://doi.org/10.1038/s41433-021-01681-0
  15. Borrelli E, Barresi C, Battista M, Berni A, Ricardi F, Cascavilla ML, Reibaldi M, Bandello F. Prevalence and morphologic biomarkers of metamorphopsia in eyes with “resolved” chronic central serous chorioretinopathy. Retina. 2023;43(9):1563-1572. https://doi.org/10.1097/IAE.0000000000003845
  16. Drakon AK, Pateyuk LS, Sheludchenko VM, Korchazhkina NB. Current approaches in the treatment of central serous chorioretinopathy. A review. Ophthalmology. 2021;18(3S):660-665. (In Russ.). https://doi.org/10.18008/1816-5095-2021-3S-660-665
  17. Voronin GV, Yusef NY, Kazaryan EE, Smirnova TV, Khasyanova MV. Morphological and functional features of bilateral avascular retinal pigment epithelium detachment (a case report). Russian Annals of Ophthalmology. 2020;136(4):235-242. (In Russ.). https://doi.org/10.17116/oftalma2020136042235
  18. WHO. World report on vision. Accessed January 15, 2024. https://bit.ly/2NiwF6H
  19. Budzinskaya MV, Plyukhova AA, Alkharki L. Modern trends in anti-VEGF therapy for age-related macular degeneration. Russian Annals of Ophthalmology. 2023;139(3-2):46-50. (In Russ.). https://doi.org/10.17116/oftalma202313903246
  20. Melikhova MV, Gatsu MV, Boiko EV, Fokin VA, Trufanov GE. Dome-shaped macula: features of differential diagnostics with clinical examples. Russian Annals of Ophthalmology. 2018;134(3):86-94. (In Russ.). https://doi.org/10.17116/oftalma2018134386
  21. Chen Z, Liu W, Liu G, Lu P. Incidence of Metamorphopsia After Successful Rhegmatogenous Retinal Detachment Surgery: A Systematic Review and Meta-Analysis. Seminars in Ophthalmology. 2024;39(1):66-73.  https://doi.org/10.1080/08820538.2023.2279221
  22. Okamoto F. Changes in Metamorphopsia in Patients Undergoing Treatment for Vitreoretinal Disorders. Journal of Nippon Medical School. 2024;91(1):28-36.  https://doi.org/10.1272/jnms.JNMS.2024_91-114
  23. Kulikov AN, Churashov SV, Popov EM. Methods of macular rupture treatment — history and prospects. Bulletin of Pirogov National Medical & Surgical Center. 2021;16(1):135-138. (In Russ.). https://doi.org/10.25881/BPNMSC.2021.14.53.026
  24. Krasil’nikova V, Khodasevich E. Retinal vein occlusion. Ophthalmology. 2022; 12(3):392-405. (In Russ.). https://doi.org/10.34883/PI.2022.12.3.030
  25. Bálint R, Árpádffy‐Lovas T, Hári-Kovács A. A study of metamorphopsia following rhegmatogenous retinal detachment surgery. Developments in Health Sciences. 2025;7(2):33-37.  https://doi.org/10.1556/2066.2024.00064
  26. Ocal O, Dogan ME, Bilgin AB. Quantitative evaluation of metamorphopsia with M-CHARTS™ and evaluation of retinal morphologic changes by optical coherence tomography before and after pars plana vitrectomy in patients with idiopathic epiretinal membrane. Journal Français d’Ophtalmologie. 2024;47(7):104210. https://doi.org/10.1016/j.jfo.2024.104210
  27. Amsler M. L’examen qualitatif de la fonction maculaire [The qualitative examination of the macular function]. Ophthalmologica. 1947;114(4-5):248-261. (In French).
  28. Ayhan I, Doyle E, Zanker J. Measuring image distortions arising from age-related macular degeneration: An Iterative Amsler Grid (IAG). MedComm. 2022;3(1):e107. https://doi.org/10.1002/mco2.107
  29. Suwal B, Khadka D, Shrestha A, Suwal R, Khatri B. Quantification of Metamorphopsia in Resolved Idiopathic Central Serous Chorioretinopathy: An Analysis Using M-CHARTS, Amsler Grid, and Optical Coherence Tomography. Clinical Ophthalmology. 2024;18:937-942.  https://doi.org/10.2147/OPTH.S456556
  30. Shpak AA, Zhuravlev AS, Avakyan FA, Kolesnik AI, Kolesnik SV, Avakyan AA. Comparative analysis of tabular and software methods for quantifying metamorphopsia. Ophthalmology reports. 2024;17(1):21-28. (In Russ.). https://doi.org/10.17816/OV611113
  31. Bjerager J, Schneider M, Potapenko I, van Dijk EHC, Faber C, Grauslund J, Pfau K, Huemer J, Muttuvelu DV, Rasmussen MLR, Sabaner MC, Subhi Y. Diagnostic Accuracy of the Amsler Grid Test for Detecting Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-analysis. JAMA Ophthalmology. 2023;141(4):315-323.  https://doi.org/10.1001/jamaophthalmol.2022.6396
  32. Achard OA, Safran AB, Duret FC, Ragama E. Role of the completion phenomenon in the evaluation of Amsler grid results. American Journal of Ophthalmology. 1995;120(3):322-329.  https://doi.org/10.1016/s0002-9394(14)72162-2
  33. Matsumoto C. A new method for quantification of metamorphopsia using M-CHARTSTM. Japanese Journal of Clinical Ophthalmology. 2000;54(3): 373-377. 
  34. Matsumoto C, Arimura E, Okuyama S, Takada S, Hashimoto S, Shimomura Y. Quantification of metamorphopsia in patients with epiretinal membranes. Investigative Ophthalmology & Visual Science. 2003;44(9):4012-4016. https://doi.org/10.1167/iovs.03-0117
  35. Oquendo PL, Figueiredo N, Francisconi CLM, Juncal V, Marafon S, Naidu SC, Pecaku A, Demian S, Melo IM, Longwell J, Muni RH. Validation of M-CHARTS for quantitative assessment of metamorphopsia following rhegmatogenous retinal detachment repair. Retina. 2024;44(7):1157-1164. https://doi.org/10.1097/IAE.0000000000004071
  36. Milanova G. M-CHARTS method for quantitative assessment of metamorphopsia in patients with ERM. Bulgarian Review of Ophthalmology. 2023; 67(1):14-20.  https://doi.org/10.14748/bro.v67i1.8743
  37. Ocal O, Dogan M, Bilgin A. Quantitative Evaluation of Metamorphopsia Score Before and After Pars Plana Vitrectomy Operation in Patients with Idiopatic Epiretinal Membranes Using The M-ChartsTM and Comparison with Oct Parameters. Preprint. 2023. Available at Research Square. https://doi.org/10.21203/rs.3.rs-3287008/v1
  38. Takeyama A, Imamura Y, Fujimoto T, Iida T, Komiya Y, Shibata M, Ishida M. Predictors for metamorphopsia in eyes undergoing macular hole surgery. Scientific Reports. 2023;13(1):810.  https://doi.org/10.1038/s41598-023-28031-2
  39. Nakano E, Ota T, Jingami Y, Nakata I, Hayashi H, Yamashiro K. Correlation between metamorphopsia and disorganization of the retinal inner layers in eyes with diabetic macular edema. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2019;257(9):1873-1878. https://doi.org/10.1007/s00417-019-04393-0
  40. Lifton JA, Moshfeghi AA. Elimination of a False-Negative Result With the M-CHARTS Metamorphopsia Assessment Tool Achieved Through Sampling Oblique Axes. Ophthalmic Surgery, Lasers and Imaging Retina. 2019; 50(11):734-736.  https://doi.org/10.3928/23258160-20191031-09
  41. Arimura E, Matsumoto C, Okuyama S, Takada S, Hashimoto S, Shimomura Y. Quantification of metamorphopsia in a macular hole patient using M-CHARTS. Acta Ophthalmologica. 2007;85(1):55-59.  https://doi.org/10.1111/j.1600-0420.2006.00729.x
  42. Bočková M, Veselý P, Beneš P. Usage of digital D Chart test as a modification of Amsler grid in ophthalmology and optometry. Czech and Slovak Ophtalmology. 2020;76(4):160-164.  https://doi.org/10.31348/2020/25
  43. Hazelwood JE, Ah-See K, Young SL, Bennett HGB, Khan A, Goudie CR. Title — Long term outcomes of vitrectomy and ERM peel: Can pre-operative metamorphopsia measured using the D-Chart help improve surgical candidate selection? Graefe’s Archive for Clinical and Experimental Ophthalmology. 2024;262(11):3475-3481. https://doi.org/10.1007/s00417-024-06514-w
  44. McGowan G, Yorston D, Strang NC, Manahilov V. D-CHART: A Novel Method of Measuring Metamorphopsia in Epiretinal Membrane and Macular Hole. Retina. 2016;36(4):703-708.  https://doi.org/10.1097/IAE.0000000000000778
  45. Mohaghegh N, Ghafar-Zadeh E, Magierowski S. Recent Advances of Computerized Graphical Methods for the Detection and Progress Assessment of Visual Distortion Caused by Macular Disorders. Vision. 2019;3(2):25.  https://doi.org/10.3390/vision3020025
  46. Fink W, Sadun AA. Three-dimensional computer-automated threshold Amsler grid test. Journal of Biomedical Optics. 2004;9(1):149-153.  https://doi.org/10.1117/1.162595
  47. Kovalevskaya MA, Milyutkina SO. Analysis of structure-function relationships in patients with diabetic macular edema. Point of View. East-West. 2019; (2):59-61. (In Russ.). https://doi.org/10.25276/2410-1257-2019-2-59-61
  48. Kovalevskaya MA, Milyutkina SO. Changes in visual function in patients with diabetic macular edema. XVIII All-Russian School of Ophthalmologist: collection of scientific papers. 2019:68-73. (In Russ.). https://doi.org/10.30808/978-5-6040782-2019-1-1-68-72
  49. Jivrajka RV, Kim JK, Fink W, Sadun AA, Sebag J. Quantitative analysis of central visual field defects in macular edema using three-dimensional computer-automated threshold Amsler grid testing. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2009;247(2):165-170.  https://doi.org/10.1007/s00417-008-0971-8
  50. Goldstein M, Loewenstein A, Barak A, Pollack A, Bukelman A, Katz H, Springer A, Schachat AP, Bressler NM, Bressler SB, Cooney MJ, Alster Y, Rafaeli O, Malach R; Preferential Hyperacuity Perimeter Research Group. Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration. Retina. 2005; 25(3):296-303.  https://doi.org/10.1097/00006982-200504000-00008
  51. Faes L, Bodmer NS, Bachmann LM, Thiel MA, Schmid MK. Diagnostic accuracy of the Amsler grid and the preferential hyperacuity perimetry in the screening of patients with age-related macular degeneration: systematic review and meta-analysis. Eye. 2014;28(7):788-796.  https://doi.org/10.1038/eye.2014.104
  52. Stur M, Manor Y. Long-term monitoring of age-related macular degeneration with preferential hyperacuity perimetry. Ophthalmic Surgery Lasers & Imaging. 2010;41(6):598-606.  https://doi.org/10.3928/15428877-20100830-05
  53. Matos ACR, Gaspar CGF, Duarte MA da E, et al. Perimetria de hiperacuidade preferencial no estudo do edema macular diabético [Preferential hyperacuity perimetry in the study of diabetic macular edema]. Saúde & Tecnologia. 2012;(8):31-38.  https://doi.org/10.25758/SET.534
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.